期刊
DISEASES OF THE ESOPHAGUS
卷 20, 期 5, 页码 365-371出版社
OXFORD UNIV PRESS INC
DOI: 10.1111/j.1442-2050.2007.00730.x
关键词
angiogenesis inhibitor; cyclin-dependent kinase; epidermal growth factor; monoclonal; protein kinase inhibitor
Esophageal cancer is highly aggressive and is the sixth leading cause of cancer death worldwide. Recent advances in multimodality chemoradiotherapy and surgery has improved survival in patients with loco-regional disease, but most patients with advanced stage esophageal cancer have a poor prognosis. Elucidation of the processes involved in esophageal carcinogenesis has identified a number of promising novel targets for therapy. This review focuses on the current status of targeted therapies with potential application to the treatment of advanced esophageal and gastroesophageal junction cancer. The future challenge is to confirm the efficacy of these targeted agents in appropriately selected esophageal cancer patients, and successfully integrate these agents into effective therapies for all stages and subtypes of disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据